BOOK
Controversies in Spinal and Cranial Surgery, An Issue of Neurosurgery Clinics of North America, E-Book
Russell R. Lonser | Daniel K. Resnick
(2017)
Additional Information
Book Details
Abstract
This issue of Neurosurgery Clinics focuses on Controversies in Spinal and Cranial Surgery. Article topics will include:Sacro-illiac Fusion; Interspinous Spacers;Bone Morphogenetic Protein, Platelet Concentrates and Other Biologics; MIS decompression; Pipeline flow diversion in subarachnoid hemorrhage; Direct versus indirect bypass for moyamoya disease; Management of prenatally diagnosed myelomeningocele; Management of incidental aneurysm; Surgical management of incidental low-grade glioma; and more!
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Controversies in Spinaland Cranial Surgery\r | i | ||
Copyright\r | ii | ||
Contributors | iii | ||
CONSULTING EDITORS | iii | ||
EDITORS | iii | ||
AUTHORS | iii | ||
Contents | vii | ||
Preface: Current Controversies in Spinal and Cranial Surgery | vii | ||
Spinal Surgery | vii | ||
The Sacroiliac Joint\r | vii | ||
Sacroiliac Fusion: Another “Magic Bullet” Destined for Disrepute\r | vii | ||
Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication?\r | vii | ||
Bone Morphogenic Protein Use in Spinal Surgery\r | vii | ||
Lumbar Radiculopathy in the Setting of Degenerative Scoliosis: MIS Decompression and Limited Correction are Better Options\r | viii | ||
The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity\r | viii | ||
Cranial Surgery\r | viii | ||
Hemicraniectomy for Ischemic and Hemorrhagic Stroke: Facts and Controversies\r | viii | ||
Direct Versus Indirect Bypass for Moyamoya Disease\r | viii | ||
Flow Diversion after Aneurysmal Subarachnoid Hemorrhage\r | ix | ||
Management of Small Incidental Intracranial Aneurysms\r | ix | ||
Surgical Management of Incidental Gliomas\r | ix | ||
Reoperation for Recurrent Glioblastoma Multiforme\r | ix | ||
Surgical Treatment of Trigeminal Neuralgia\r | x | ||
Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele\r | x | ||
NEUROSURGERY CLINICS OF NORTH AMERICA\r | xi | ||
FORTHCOMING ISSUES | xi | ||
October 2017 | xi | ||
January 2018 | xi | ||
RECENT ISSUES | xi | ||
April 2017 | xi | ||
January 2017 | xi | ||
Preface\r | xiii | ||
Current Controversies in Spinal and Cranial Surgery | xiii | ||
The Sacroiliac Joint | 301 | ||
Key points | 301 | ||
REFERENCES | 311 | ||
Sacroiliac Fusion | 313 | ||
Key points | 313 | ||
INTRODUCTION | 313 | ||
EPIDEMIOLOGY | 313 | ||
ANATOMY | 314 | ||
POTENTIAL CAUSES OF SACROILIAC JOINT PAIN | 315 | ||
DIAGNOSIS | 315 | ||
TREATMENT | 316 | ||
SUMMARY | 318 | ||
ACKNOWLEDGMENTS | 318 | ||
REFERENCES | 318 | ||
Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication? | 321 | ||
Key points | 321 | ||
INTRODUCTION | 321 | ||
INTERSPINOUS SPACER DEVELOPMENT | 322 | ||
SURGICAL VERSUS NONSURGICAL MANAGEMENT OF LUMBAR SPINAL STENOSIS | 322 | ||
CONFLICTING EVIDENCE FOR INTERSPINOUS SPACER USE | 323 | ||
INDICATIONS FOR INTERSPINOUS SPACER USE | 324 | ||
SURGICAL TECHNIQUE/PROCEDURE | 325 | ||
SURGICAL COMPLICATIONS AND MANAGEMENT | 325 | ||
FUTURE DIRECTIONS AND CONSENSUS STATEMENT | 325 | ||
SUMMARY | 328 | ||
REFERENCES | 328 | ||
Bone Morphogenic Protein Use in Spinal Surgery | 331 | ||
Key points | 331 | ||
INTRODUCTION | 331 | ||
DEVELOPMENT OF BONE MORPHOGENIC PROTEIN | 332 | ||
CONTROVERSY SURROUNDING BONE MORPHOGENIC PROTEIN USE | 332 | ||
THE CURRENT USE OF BONE MORPHOGENIC PROTEIN | 333 | ||
SUMMARY | 334 | ||
ACKNOWLEDGMENTS | 334 | ||
REFERENCES | 334 | ||
Lumbar Radiculopathy in the Setting of Degenerative Scoliosis | 335 | ||
Key points | 335 | ||
INTRODUCTION | 335 | ||
CASE EXAMPLE | 336 | ||
TREATMENT RATIONALE AND DISCUSSION | 337 | ||
SUMMARY | 339 | ||
REFERENCES | 339 | ||
The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity | 341 | ||
Key points | 341 | ||
INTRODUCTION | 341 | ||
The Relationship Between Deformity and Symptomatic Radiculopathy | 342 | ||
VARIABILITY IN APPROACHES TO CARE | 342 | ||
DECOMPRESSION ALONE | 342 | ||
DECOMPRESSION WITH LIMITED FUSION | 343 | ||
DECOMPRESSION WITH EXTENSIVE FUSION | 344 | ||
SUMMARY | 345 | ||
REFERENCES | 345 | ||
Hemicraniectomy for Ischemic and Hemorrhagic Stroke | 349 | ||
Key points | 349 | ||
INTRODUCTION | 350 | ||
ISCHEMIC HEMISPHERIC STROKE (SUPRATENTORIAL) | 350 | ||
Epidemiology | 350 | ||
Pathophysiology of Malignant Stroke | 350 | ||
Microscopic and cellular changes | 350 | ||
Macroscopic pathology | 350 | ||
Predictors of Progression | 350 | ||
Time since stroke | 350 | ||
National Institutes of Health stroke scale | 351 | ||
Computed tomography | 351 | ||
MRI | 351 | ||
Best Medical Management | 351 | ||
Data on Decompressive Craniectomy Before Randomized Controlled Trials | 351 | ||
Data from Randomized Controlled Trials on Hemicraniectomy for Malignant Ischemic Stroke | 352 | ||
Study design | 352 | ||
Results of the randomized controlled trials | 352 | ||
Effects on mortality (MRS 6) | 352 | ||
Effects on moderately severe disability (MRS 4) | 352 | ||
Effects on severe disability (MRS 5) | 353 | ||
Effect on MRS 0 to 3 (good outcome) | 353 | ||
Effect of timing of surgery on outcome | 353 | ||
Dominant hemisphere involvement | 353 | ||
Additional evidence | 353 | ||
Limitations of the randomized controlled trials | 353 | ||
Surgical Technique | 354 | ||
Postoperative Management | 354 | ||
Complications of Decompressive Craniectomy | 354 | ||
Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke: A Case Illustration | 354 | ||
ISCHEMIC POSTERIOR FOSSA STROKE (INFRATENTORIAL) | 354 | ||
Existing Evidence | 355 | ||
Surgical Technique | 356 | ||
Decompressive Craniectomy for Posterior Fossa Ischemic Stroke: A Case Illustration | 356 | ||
HEMORRHAGIC STROKE | 356 | ||
Overview of Intracerebral Hemorrhage | 356 | ||
Pathophysiology of Spontaneous Intracerebral Hemorrhage | 356 | ||
Decompressive Craniectomy for Supratentorial Intracerebral Hemorrhage | 357 | ||
Decompressive Craniectomy for Hemorrhagic Stroke: A Case Illustration | 357 | ||
Decompressive Craniectomy for Posterior Fossa Hemorrhage | 357 | ||
STATE OF CURRENT KNOWLEDGE AND FUTURE TRIAL AREAS | 358 | ||
ACKNOWLEDGMENTS | 358 | ||
REFERENCES | 358 | ||
Direct Versus Indirect Bypass for Moyamoya Disease | 361 | ||
Key points | 361 | ||
INTRODUCTION | 361 | ||
PATIENT EVALUATION OVERVIEW | 362 | ||
NONSURGICAL TREATMENT OPTIONS | 362 | ||
SURGICAL TREATMENT OPTIONS | 362 | ||
Direct Bypass Technique | 362 | ||
Indirect Bypass Techniques | 365 | ||
INDIRECT TECHNIQUES USING DISTANT TISSUE | 367 | ||
DISCUSSION | 370 | ||
Benefits of Revascularization | 370 | ||
Direct Versus Indirect Bypass and Outcomes | 370 | ||
SUMMARY | 372 | ||
REFERENCES | 373 | ||
Flow Diversion after Aneurysmal Subarachnoid Hemorrhage | 375 | ||
Key points | 375 | ||
INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL ESTABLISHED ENDOVASCULAR TREATMENT AS THE PRIMARY TREATMENT OF RUPTURED ANEURYSMS | 375 | ||
WHO GETS CLIPPED AFTER THE INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL? | 376 | ||
ENDOVASCULAR DEVICES ARE DEVELOPING AT A RAPID PACE TO ENABLE TREATMENT OF MORE COMPLEX ANEURYSM MORPHOLOGIES AND TO DECREA ... | 376 | ||
OUR PROTOCOL FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE | 376 | ||
WHAT IS FLOW DIVERSION? | 377 | ||
FLOW DIVERSION IS NOT THE PREFERRED TREATMENT AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE | 377 | ||
PATIENT SELECTION FOR FLOW DIVERSION AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE | 377 | ||
ANTIPLATELET THERAPY | 377 | ||
FLOW-DIVERSION TECHNIQUE | 377 | ||
OUR EXPERIENCE WITH FLOW DIVERSION AFTER SUBARACHNOID HEMORRHAGE | 378 | ||
REVIEW OF THE LITERATURE | 381 | ||
Hemorrhagic Risk with Dual Antiplatelet Agents After Subarachnoid Hemorrhage | 385 | ||
Blister Aneurysms | 385 | ||
Risk of Dome Protection and Delayed Flow Diversion After Aneurysmal Rupture | 385 | ||
Flow Diversion Is Associated with Better Long-term Aneurysm Occlusion Rates | 386 | ||
Coiling-assisted Flow Diversion | 386 | ||
SHIELD TECHNOLOGY MAY INCREASE THE SAFETY OF FLOW DIVERSION IN ANEURYSMAL SUBARACHNOID HEMORRHAGE | 386 | ||
SUMMARY | 386 | ||
DISCLOSURE | 386 | ||
REFERENCES | 387 | ||
Management of Small Incidental Intracranial Aneurysms | 389 | ||
Key points | 389 | ||
INTRODUCTION | 389 | ||
PATIENT EVALUATION OVERVIEW | 389 | ||
MEDICAL TREATMENT OPTIONS | 392 | ||
SURGICAL TREATMENT OPTIONS | 392 | ||
EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS | 393 | ||
SUMMARY/DISCUSSION | 395 | ||
REFERENCES | 395 | ||
Surgical Management of Incidental Gliomas | 397 | ||
Key points | 397 | ||
INTRODUCTION | 397 | ||
GLIOMA GENETICS | 398 | ||
DIAGNOSTIC IMAGING | 398 | ||
STEREOTACTIC BIOPSY | 399 | ||
MICROSURGICAL RESECTION | 399 | ||
FUNCTIONAL MAPPING | 401 | ||
MALIGNANT TRANSFORMATION | 402 | ||
ADVANCED TECHNOLOGIES | 403 | ||
SUMMARY | 403 | ||
REFERENCES | 403 | ||
Reoperation for Recurrent Glioblastoma Multiforme | 407 | ||
Key points | 407 | ||
INTRODUCTION | 407 | ||
METHODS | 408 | ||
RESULTS | 408 | ||
DISCUSSION | 409 | ||
Inclusion and Exclusion Criteria | 409 | ||
Indications for Surgery | 414 | ||
Survival Following Reoperation for Recurrent or Progressive Glioblastoma Multiforme | 414 | ||
Extent of resection | 424 | ||
Progression-free survival | 424 | ||
Complications | 424 | ||
Bias | 425 | ||
SUMMARY | 425 | ||
ACKNOWLEDGMENTS | 425 | ||
REFERENCES | 425 | ||
Surgical Treatment of Trigeminal Neuralgia | 429 | ||
Key points | 429 | ||
INTRODUCTION | 429 | ||
MICROVASCULAR DECOMPRESSION | 429 | ||
Success Rates | 429 | ||
Complications | 430 | ||
PERCUTANEOUS TREATMENTS | 431 | ||
Percutaneous Radiofrequency Rhizotomy | 431 | ||
Success rates | 431 | ||
Complications | 431 | ||
Percutaneous Glycerol Rhizotomy | 432 | ||
Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele | 439 | ||
Key points | 439 | ||
INTRODUCTION | 439 | ||
POSTNATAL REPAIR OF MYELOMENINGOCELE | 440 | ||
PRENATAL DIAGNOSIS OF MYELOMENINGOCELE | 441 | ||
Prenatal Imaging Assessment: Fetal MRI | 443 | ||
PRENATAL REPAIR OF MYELOMENINGOCELE | 443 | ||
Outcomes of Postnatal Versus Prenatal Myelomeningocele Correction | 444 | ||
Future Perspectives of Myelomeningocele Treatment | 446 | ||
SUMMARY | 447 | ||
REFERENCES | 447 | ||
Index | 449 |